Jan 7 (Reuters) - The United Arab Emirates' drug regulator has recalled certain Nestle infant formula products after the company recalled specific batches over a potential toxin risk, the state news agency (WAM) reported on Wednesday.
The Emirates Drug Establishment said no illness or adverse events linked to the affected batches have been reported or confirmed, WAM added.
The Qatari ministry of public health has also warned consumers against using specific batches of Nestle infant formula products over suspected contamination with cereulide toxin, the Qatari state news agency reported.
Nestle said late on Monday it was recalling specific batches of its SMA infant formula and follow-on formula due to the potential presence of a toxin that could lead to nausea, vomiting and abdominal cramps.
(Reporting by Ahmed Tolba and Yomna Ehab in Cairo; Editing by Chris Reese and David Gregorio)
LATEST POSTS
- 1
Instructions to Pick the Right Toothpaste for Your Dental Requirements - 2Figure out How to Augment the Advantages of a Web-based Degree
- 3Steinmeier honours Italian 'guest workers' who rebuilt German economy
- 4NASA releases stunning first images of Earth taken by the Artemis II astronauts
- 5Hot Electric Vehicles for 2023
- As nations push for more ambition at climate talks, chairman says they may get it
- Language Learning Stages: Which One Gets Your Vote?
- Bestselling author Colleen Hoover reveals cancer journey
- The Best Business visionaries Under 30
- Step by step instructions to Lessen Your Gamble of Creating Cellular breakdown in the lungs
- From candy cane fishing to ornament switcharoo, here are some of the best games you can play with your loved ones this holiday season
- From blowouts to big interiors, ‘Tuscan Mom’ style is Gen Z’s answer to beige burnout
- 'A perfect storm': Airlines cut flights and increase airfares as jet fuel price spikes
- More parents refusing vitamin K shots for newborns, study finds
